The average one-year price target for ENDRA Life Sciences (NasdaqCM:NDRA) has been revised to $27.54 / share. This is a decrease of 10.00% from the prior estimate of $30.60 dated April 7, 2026. The ...
ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc. (NDRA) (NASDAQ: NDRA), a pioneer in imaging technologies for the early detection and monitoring of metabolic liver disease, today announced ...
Achieved Intraclass Correlation Coefficient (ICC) of 0.89 with standard error of measurement (SEM) of 3.3% using independent operators ANN ARBOR, Mich., February 26 ...
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), today announced it will host an offsite panel discussion with ...
ENDRA Life Sciences Inc. Annual cash flow by MarketWatch. View NDRA net cash flow, operating cash flow, operating expenses and cash dividends.
ANN ARBOR, MI / ACCESSWIRE / June 8, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NDRA), a pioneer of enhanced ultrasound technologies, today announced that the Medical College of Wisconsin ("MCW") a ...
ENDRA Lifesciences filed a 13G form showing that S.H.N. Financial Investments had a 9.99% passive stake. S.H.N Financial Investments owns approximately 7.9 million shares in the company. Ready to turn ...
ENDRA Life Sciences Inc (NASDAQ:NDRA) shares are trading lower by some 65% to $0.07 during Tuesday’s session. The company priced a public offering of 61,538,461 shares of common stock (or pre-funded ...
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), announces the issuance of five new patents, including three in ...
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring These thresholds ...
View ENDRA Life Sciences Inc. NDRA stock quote prices, financial information, real-time forecasts, and company news from CNN.
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care Achieved Intraclass ...